Nuformix (NFX) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 May 2025 02:24 PM
RNS
Total Voting Rights
29 May 2025 07:00 AM
RNS
Confirmation of European ODD for NXP002
23 May 2025 01:08 PM
RNS
Publication of a Prospectus
22 May 2025 07:00 AM
RNS
£210,000 Placing
19 May 2025 07:00 AM
RNS
Attendance at American Thoracic Society Congress
02 May 2025 07:00 AM
RNS
Half-year Report
30 Apr 2025 07:00 AM
RNS
Confirmation of European Orphan Drug Designation
29 Apr 2025 07:00 AM
RNS
Change of Registered Office and Company Secretary
14 Apr 2025 12:22 PM
RNS
Correction - Exercise of Warrants
14 Apr 2025 07:00 AM
RNS
Exercise of Warrants
09 Apr 2025 07:00 AM
RNS
NXP002 Update
20 Mar 2025 11:10 AM
RNS
Result of AGM
28 Feb 2025 12:30 PM
RNS
Total Voting Rights
14 Feb 2025 02:18 PM
RNS
Posting of Annual Report and Notice of AGM
30 Jan 2025 07:00 AM
RNS
£168,750 Placing
29 Jan 2025 07:00 AM
RNS
Annual Results for period ended 30 September 2024
28 Jan 2025 07:00 AM
RNS
NXP002 ODD Application Submitted
13 Jan 2025 07:00 AM
RNS
NXP002 Orphan Drug Designation Draft Application
29 Nov 2024 05:00 PM
RNS
Total Voting Rights
05 Nov 2024 02:25 PM
RNS
Director/PDMR Dealings
04 Nov 2024 10:17 AM
RNS
Result of General Meeting
16 Oct 2024 01:37 PM
RNS
Publication of Prospectus & Notice of GM
20 Sep 2024 02:24 PM
RNS
£300,000 Fundraise
18 Jun 2024 07:00 AM
RNS
Half-year Report
17 Jun 2024 07:00 AM
RNS
Patent Update
19 Mar 2024 02:39 PM
RNS
Result of AGM
01 Mar 2024 07:00 AM
RNS
Subscription to raise £150,000
15 Jan 2024 11:30 AM
RNS
Posting of Annual Report and Notice of AGM
03 Jan 2024 07:00 AM
RNS
Results for the period ended 30 September 2023
18 Dec 2023 07:00 AM
RNS
NXP001 Update
23 Oct 2023 07:00 AM
RNS
Notice of Allowance of NXP002 Patent in Japan
18 Sep 2023 07:00 AM
RNS
NXP001 Update
24 Aug 2023 01:22 PM
RNS
Result of Annual General Meeting
31 Jul 2023 02:00 PM
RNS
Notice of AGM
31 Jul 2023 02:00 PM
RNS
Notice of AGM
26 Jul 2023 02:55 PM
RNS
Holding(s) in Company
02 Jun 2023 07:00 AM
RNS
Investor Online Q&A
25 May 2023 07:00 AM
RNS
Change of Auditor
22 May 2023 07:00 AM
RNS
Unaudited Interim Report
18 May 2023 07:00 AM
RNS
NXP002 Inflammation and Duration of Action Update
26 Apr 2023 10:55 AM
RNS
Holding(s) in Company
17 Apr 2023 07:00 AM
RNS
Subscription to raise £70,000 & issue of Warrants
27 Mar 2023 07:00 AM
RNS
NXP002 Update
13 Mar 2023 07:00 AM
RNS
Change of Accounting Reference Date
15 Feb 2023 07:00 AM
RNS
NXP002 Update
03 Jan 2023 01:37 PM
RNS
Holding(s) in Company
20 Dec 2022 01:00 PM
EQS
Nuformix hoping to 'initiate discussions with m...
20 Dec 2022 07:00 AM
RNS
NXP004 Update
13 Dec 2022 07:00 AM
RNS
Half-year Report
05 Dec 2022 07:00 AM
RNS
Resignation of Auditor

Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis. It is listed in London under the ticker NFX.

NFX share price launched at 2p in 2017.

UK 100

Latest directors dealings